CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Company Snapshot
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tianjin Zhong Xin Pharmaceutical Group Corporation Limited with three other companies in this sector in China: Dong-E-E-Jiao Co Ltd (2016 sales of 6.32 billion Chinese Renmimbi [US$960.52 million] of which 89% was Medicine Manufacturing), Zhejiang Conba Pharmaceutical Co., Ltd. (6.02 billion Chinese Renmimbi [US$915.25 million] of which 65% was Manufacturing), and Zhejiang Medicine Co., Ltd. (5.28 billion Chinese Renmimbi [US$802.64 million] of which 44% was Life Nourishment).

Sales Analysis. During the year ended December of 2016, sales at Tianjin Zhong Xin Pharmaceutical Group Corporation Limited were 6.18 billion Chinese Renmimbi (US$939.49 million). This is a decrease of 12.7% versus 2015, when the company's sales were 7.08 billion Chinese Renmimbi. Contributing to the drop in overall sales was the 24.1% decline in Western Medicine, from 2.16 billion Chinese Renmimbi to 1.64 billion Chinese Renmimbi. There were also decreases in sales in Chinese Medicine (down 6.8% to 4.07 billion Chinese Renmimbi) and Others (down 15.2% to 471.65 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited
  Stock Performance Chart for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (10/13/2017): 17.67
(Figures in Chinese Renmimbi)
1 Week n/a   13 Weeks 2.8%  
4 Weeks 1.0%   52 Weeks 2.9%  
 
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Key Data:
  Ticker: 600329 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 6,178,822,000
(Year Ending Jan 2017).
Employees: 4,274
  Currency: Chinese Renmimbi Market Cap: 13,585,987,253
  Fiscal Yr Ends: December Shares Outstanding: 768,873,076
  Share Type: A Gu Closely Held Shares: 343,520,784
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.